Subconjunctival Aflibercept for the Treatment of Formed Corneal Neovascularization-Reference-Cited by-同舟云学术

Subconjunctival Aflibercept for the Treatment of Formed Corneal Neovascularization

Published:2020-05-14 Issue:4 Volume:47 Page:180-184
ISSN:1542-2321
Container-title:Eye & Contact Lens: Science & Clinical Practice
language:en
Short-container-title:

Author:

Sella Ruti,Ben Ishai Meydan,Livny Eitan,Nahum Yoav,Bahar Irit

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology

Reference41 articles.

1. Corneal angiogenic privilege: Angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American ophthalmological society thesis);Azar;Trans Am Ophthalmol Soc,2006

2. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis;Bock;Invest Ophthalmol Vis Sci,2007

3. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: Outcome of an expert roundtable;Cursiefen;Br J Ophthalmol,2012

4. Comparison of subconjunctival aflibercept and betamethasone for the treatment of formed corneal neovascularization in a rabbit model;Eiger-Moscovich;Ophthalmic Res,2019

5. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits;Kang;Cornea,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation;Ophthalmology Science;2024-07

2. Available Therapeutic Options for Corneal Neovascularization: A Review;International Journal of Molecular Sciences;2024-05-17

3. Current trends in the management of corneal neovascularization;Current Opinion in Ophthalmology;2024-05-14

4. Management of corneal neovascularization: Current and emerging therapeutic approaches;Indian Journal of Ophthalmology;2024-04-20

5. Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno‐associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation;Journal of Ophthalmology;2024-01